April Shamy

Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an <scp>MDS</scp>‐<scp>CAN</scp> prospective study

Rena Buckstein, Richard A. Wells, Nancy Zhu et al. · British Journal of Haematology · 2016 · 97 citations · Full text

Medicine, Biostatistics, Frailty +16

Overall survival in lower <scp>IPSS</scp> risk <scp>MDS</scp> by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an <scp>MDS</scp>‐<scp>CAN</scp> analysis

Heather A. Leitch, Ambica Parmar, Richard A. Wells et al. · British Journal of Haematology · 2017 · 64 citations · Full text

Medicine, Hematology, Iron Metabolism Disorders +13

Targeting the Apoptotic Pathway with BCL-2 Inhibitors Sensitizes Primary Chronic Lymphocytic Leukemia Cells to Vesicular Stomatitis Virus-Induced Oncolysis

Vanessa Tumilasci, Stéphanie Olière, April Shamy et al. · Journal of Virology · 2008 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

VSV Oncolysis in Combination With the BCL-2 Inhibitor Obatoclax Overcomes Apoptosis Resistance in Chronic Lymphocytic Leukemia

Sara Samuel, Vanessa Tumilasci, Stéphanie Olière et al. · Molecular Therapy · 2010 · 42 citations · Full text

Medicine, Oncology, Pharmacology +13

BCL-2 Inhibitors Sensitize Therapy-resistant Chronic Lymphocytic Leukemia Cells to VSV Oncolysis

Sara Samuel, Vladimir Beljanski, Julien van Grevenynghe et al. · Molecular Therapy · 2013 · 31 citations · Full text

Life Sciences, Cancer Biology, Oncology +13